Skip to content
TrustList
Solasta Ventures logo
Investor

Solasta Ventures

Healthcare venture capital firm investing in therapeutics and discovery platforms for unmet medical needs

  • Washington
  • Alexandria
  • Qatar
  • Business
  • +10 more
Solasta Ventures cover

About Solasta Ventures

Healthcare capital from a Korean parent

Solasta Ventures is part of the South Korean group Aju IB Investment and invests in healthcare. In the United States it traded as Aju IB Investment before the rename. The company says it backs businesses that advance care for diseases with unmet medical needs, and it looks for therapeutics and discovery platforms with the potential to change patient outcomes.

How the investment team works

According to the company, its team has more than thirty years of combined experience in healthcare investment and drug development. It pairs that scientific background with a wide professional network. Its investments fall into two groups. The first is therapeutics, meaning drug developers with promising candidates. The second is discovery platforms, which are technologies that could improve outcomes across many programs. Solasta also presents its scientific and industry contacts as a resource, so portfolio companies can reach partners and collaborators.

Ensoma and the in vivo cell therapy round

The clearest example in the material is Ensoma, a Boston company developing one-time treatments that engineer cells of the blood-forming system inside the body rather than outside it. Its Engenious platform uses a delivery particle that carries no viral genes and can hold a large payload of DNA, which the company says allows several gene modification tools to be combined in a single treatment. Solasta is named among the new investors in a Series B financing co-led by Arix Bioscience and 5AM Ventures.

Ensoma also agreed to acquire Twelve Bio, a Danish gene editing company that has re-engineered the CRISPR-Cas12a enzyme for DNA editing. Twelve Bio's research began at the Novo Nordisk Foundation center at the University of Copenhagen. Completion of that deal depends on clearance under Danish foreign direct investment rules.

Why lead investors see single-treatment cell medicine as significant

One of the lead investors in that round says a single outpatient treatment could let a patient's own cells be engineered to treat disease. It argues that this would open new diseases and new countries to in vivo genomic medicine and would reduce much of the logistical burden on patients and healthcare systems. Solasta's sector focus, as the company describes it, covers healthcare and biotechnology businesses working on new drugs, with oncology and cell therapy companies among them.

TrustList summary

Solasta Ventures, Inc. is a healthcare venture capital investor, formerly known in the US as Aju IB Investment. It is a wholly owned subsidiary of Aju IB Investment, a South Korean venture capital firm.

The team backs companies that aim to improve care for diseases with unmet medical needs, drawing on scientific expertise and a wide professional network.

Products and services

  • Therapeutics investment: backing for promising drug developers.
  • Discovery platform investment: support for platforms with potential to change patient outcomes.
  • Network access: connections through its scientific and industry contacts.

Clients

Healthcare and biotechnology companies developing new medicines, including oncology and cell therapy businesses in its portfolio.

Key facts

  • Parent: Aju IB Investment, South Korea
  • Team experience: more than 30 years combined in healthcare investing and drug development

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

  • Washington
  • Alexandria
  • Qatar
  • Business
  • Collaboration
  • Logistics
  • It
  • Engineering
  • Executive
  • Science
  • Media
  • Series B
  • Partners
  • Series

Ask TrustList to introduce you to Solasta Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Solasta Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Solasta Ventures.

Solasta Ventures alternatives

Similar listings buyers compare against this one.

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Boston venture fund making early-stage investments in founders chosen for emotional intelligence

Midwest venture capital firm investing in early-stage healthcare companies, from diagnostics to life science tools

Venture firm investing in deep tech founders who turn scientific discoveries into companies

A healthcare company developing medicines and medical devices across oncology, cardiovascular and other specialisms

Dallas private investment firm buying businesses in large growing markets with a long-term outlook

A global venture capital firm investing in high-growth technology businesses tackling large-scale problems

Global venture capital partnership investing in data, technology and analytics companies, backed by RELX Group